Weill Cornell Medicine researchers reported in Cancer Cell that activated T cells release extracellular vesicles carrying DNA fragments that can boost anti-tumor immune activity. The study ties a specific vesicle-based DNA signal to enhanced tumor recognition and outlines a mechanism that could inform future combinations or engineering strategies in T-cell-based cancer immunotherapy.